Coherus BioSciences, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €195.27M +38.6% -€60.45M -37.3% -31.0% +0.38 pp N/A N/A
    (estimated) €140.85M +45.6% -€96.43M -6.3% -68.5% +0.38 pp N/A N/A
    (estimated) €96.75M +15.9% -€102.88M +4.7% -106.3% +0.11 pp N/A N/A
    (estimated) €83.49M +109.4% -€98.22M -31.0% -117.6% +2.4 pp -€74.00M +1,763.1% -88.6% -0.79 pp
    (estimated) €39.86M -82.7% -€142.27M -679.3% -356.9% -3.7 pp -€3.97M -77.4% -10.0% -0.023 pp
    €230.00M +3.8% €24.56M -112.0% 10.7% +1.0 pp -€17.61M -88.3% -7.7% +0.60 pp
    €221.63M +21.9% -€204.96M -27.2% -92.5% +0.62 pp -€150.42M -27.0% -67.9% +0.45 pp
    €181.82M -35.4% -€281.41M +6.6% -154.8% -0.61 pp -€205.98M +561.5% -113.3% -1.0 pp
    €281.34M -31.4% -€263.91M -331.6% -93.8% -1.2 pp -€31.14M -122.4% -11.1% -0.45 pp
    €409.95M +33.6% €113.93M +47.2% 27.8% +0.026 pp €138.88M +290.8% 33.9% +0.22 pp
    €306.77M +22,783.7% €77.40M -142.9% 25.2% +130 pp €35.54M -126.0% 11.6% +100 pp
    €1.34M +0.0% -€180.36M -12.1% -13,453.7% +19 pp -€136.54M -19.0% -10,184.9% +24 pp
    €1.34M -99.2% -€205.20M +87.0% -15,306.6% -150 pp -€168.62M -20.5% -12,578.0% -120 pp
    €163.79M +532.8% -€109.71M -43.0% -67.0% +6.8 pp -€211.97M +141.6% -129.4% +2.1 pp
    €25.88M -3.4% -€192.35M +156.2% -743.2% -4.6 pp -€87.73M +383.1% -339.0% -2.7 pp
    €26.80M +1,030.7% -€75.07M +62.5% -280.1% +17 pp -€18.16M -233.4% -67.8% -6.4 pp
    €2.37M +44.9% -€46.21M +62.4% -1,949.7% -2.1 pp €13.61M -195.9% 574.2% +14 pp
    €1.64M -€28.45M -1,738.7% -€14.19M -867.2%

    Notifications